Vol. 34 No. 4 (2017)

Click for printable Cover and Index

Published: 01-02-2018

  • The indications for the treatment of sarcoidosis: Wells Law

    Robert P. Baughman, Marc Judson, Athol Wells
    280-282
    DOI: https://doi.org/10.36141/svdld.v34i4.6954

  • Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD

    Shinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Kazuyuki Tabira, Ryo Kozu
    283-289
    DOI: https://doi.org/10.36141/svdld.v34i4.5549

  • Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis

    Yasunori Ichimura, Kenji Tsushima, Takuma Matsumura, Kazutaka Yamagishi, Mitsuhiro Abe, Jun Ikari, Jiro Terada, Koichiro Tatsumi
    290-299
    DOI: https://doi.org/10.36141/svdld.v34i4.5630

  • High-resolution computed tomography and magnetic resonance imaging protocols in the diagnosis of fibrotic interstitial lung disease: overview for “non-radiologists”

    Gianluigi Sergiacomi, Luca Pugliese, Francesca Ricci, Roberto Floris, Armando Fusco
    300-306
    DOI: https://doi.org/10.36141/svdld.v34i4.5792

  • Contrast-Enhanced Cardiac Magnetic Resonance: Distinction between cardiac sarcoidosis and infarction scar.

    Jan-Peter Smedema, Robert-Jan van Geus, Rene Truter, Bongani M Mayosi, Harry JGM Crijns
    307-314
    DOI: https://doi.org/10.36141/svdld.v34i4.5715

  • Assessment of lung involvement in sarcoidosis – the use of an open-source software to quantify data from computed tomography.

    Tomasz Urbankowski, Lucyna Opoka, Paweł Wojtan, Rafał Krenke
    315-325
    DOI: https://doi.org/10.36141/svdld.v34i4.6708

  • Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

    Sarah Geerts, Wim Wuyts, Ellen De Langhe, Jan Lenaerts, Jonas Yserbyt
    326-335
    DOI: https://doi.org/10.36141/svdld.v34i4.5894

  • Environmental asbestos disease: Pleural plaque volume measurement with Chest Tomography is there a correlation between pulmonary function?

    Ibrahim Güven Çoşğun, Fatma Evyapan, Nevzat Karabulut
    336-342
    DOI: https://doi.org/10.36141/svdld.v34i4.5791

  • Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry

    Thomas Barba, Alicia Marquet, Diane Bouvry, Fleur Cohen-Aubart, Marc Ruivard, Sébastien Debarbieux, Chahéra Khouatra, Alain Vighetto, Audrey de Parisot, Dominique Valeyre, Pascal Sève
    343-351
    DOI: https://doi.org/10.36141/svdld.v34i4.5817

  • The Link Between Chronic Thromboembolic PulmoChronic thromboembolic pulmonary hypertension (CTEPH) and sarcoidosis are recognized causes of nary Hypertension and Sarcoidosis: Association or Visual Masquerade?

    Rajive Tandon, Robert P. Baughman, Janice Stanley, Ali A Khan
    352-355
    DOI: https://doi.org/10.36141/svdld.v34i4.5852

  • Erectile Dysfunction is a Common Problem in Interstitial Lung Diseases

    Andreas Fløe, Ole Hilberg, Marlies Wijsenbeek, Elisabeth Bendstrup
    356-364
    DOI: https://doi.org/10.36141/svdld.v34i4.5692

  • Sarcoidosis in iron-steel industry: mini case series

    Bilge Üzmezoğlu, Cebrail Şimşek, Sevtap Gülgösteren, Berna Gebeşoğlu, Gülden Sarı, Deniz Çelik
    365-372
    DOI: https://doi.org/10.36141/svdld.v34i4.6185

  • Intrascrotal and osseous sarcoidosis mimicking intrascrotal organ cancer and bony metastasis

    Shin-ichi Nureki, Eishi Miyazaki, Mari Yamasue, Ryuichi Takenaka, Masaru Ando, Jun-ichi Kadota
    373-379
    DOI: https://doi.org/10.36141/svdld.v34i4.5523